Post job

Lexicon Pharmaceuticals CEO and executives

Executive Summary. Based on our data team's research, Lonnel Coats is the Lexicon Pharmaceuticals's CEO. Lexicon Pharmaceuticals has 225 employees, of which 23 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Lexicon Pharmaceuticals executive team is 26% female and 74% male.
  • 62% of the management team is White.
  • 9% of Lexicon Pharmaceuticals management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Lexicon Pharmaceuticals?
Share your experience

Rate Lexicon Pharmaceuticals' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Lonnel Coats

President/CEO

Lonnel Coats's LinkedIn

Lonnel Coats is a Board Member at BLUEPRINT MEDICINES CORP; Board Member at LEXICON PHARMACEUTICALS, INC.; and President/COO at Eisai Corp of North America and is based in Woodcliff Lake, New Jersey. He has worked as VP:Pharmaceuticals Bus at Eisai, Regional Director:Sales at Eisai, and President/CEO at Eisai. Lonnel works or has worked as Sales Representative at Janssen Pharmaceuticals, TRUSTEE at Univ of Sciences in Philadelphia, and VICE CHAIRMAN at Natl Pharmaceutical Council. He studied at Oakland University.

Arthur Sands

Founder

Jeffrey L. Wade J.d

Executive Vice President, Corporate and Administrative Affairs and CFO

Jeffrey L. Wade J.d's LinkedIn

Mr. Wade has been our executive vice president and chief financial officer since May 2010. He previously served as our executive vice president and general counsel from February 2000 to May 2010 and was our senior vice president and chief financial officer from January 1999 to February 2000. During his tenure with Lexicon, he has played an instrumental role in designing and negotiating corporate finance and securities transactions including the company’s initial public offering in April 2000 and private equity financing with Invus, L.P. in August 2007; the acquisition of Coelacanth Corporation that established the basis for our small molecule drug discovery efforts; and collaborations and licenses. Before joining Lexicon, Mr. Wade was a partner with the law firm of Andrews & Kurth L.L.P., where he represented companies in the biotechnology, information technology and energy industries, as well as venture capital and investment banking firms. Mr. Wade is a member of the board of directors of the Texas Healthcare and Bioscience Institute. He received his B.A. and J.D. from The University of Texas.

Raymond Debbane

Chairman

Raymond Debbane's LinkedIn

Brian T. Crum

Secretary, Senior Vice President & General Counsel

Alan J. Main Ph.d.

Executive Vice President-CMC & Supply Operations

Alan J. Main Ph.d.'s LinkedIn

Frank P. Palantoni

Board Member

Christopher J. Sobecki

Board Member

Pablo Lapuerta M.d

Executive Vice President and Chief Medical Officer

Philippe J. Amouyal

Board Member

Do you work at Lexicon Pharmaceuticals?

Does the leadership team provide a clear direction for Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals jobs

Lexicon Pharmaceuticals founders

Name & TitleBio
Arthur Sands

Founder

Lexicon Pharmaceuticals board members

Name & TitleBio
Lonnel Coats

President/CEO

Lonnel Coats's LinkedIn

Lonnel Coats is a Board Member at BLUEPRINT MEDICINES CORP; Board Member at LEXICON PHARMACEUTICALS, INC.; and President/COO at Eisai Corp of North America and is based in Woodcliff Lake, New Jersey. He has worked as VP:Pharmaceuticals Bus at Eisai, Regional Director:Sales at Eisai, and President/CEO at Eisai. Lonnel works or has worked as Sales Representative at Janssen Pharmaceuticals, TRUSTEE at Univ of Sciences in Philadelphia, and VICE CHAIRMAN at Natl Pharmaceutical Council. He studied at Oakland University.

Raymond Debbane

Chairman

Raymond Debbane's LinkedIn

Frank P. Palantoni

Board Member

Christopher J. Sobecki

Board Member

Philippe J. Amouyal

Board Member

Robert Joseph Lefkowitz

Board Member

Samuel L. Barker

Board Member

Alan S. Nies

Board Member

Judith L. Swain

Board Member

Chas Schultz

Board Member

Lexicon Pharmaceuticals leadership demographics

Lexicon Pharmaceuticals gender distribution in management team

  • The Lexicon Pharmaceuticals executive team is 26% female and 74% male.
  • Lexicon Pharmaceuticals is 42% female and 58% male company-wide.
Male
Male
74%
Company-wide: 58%
Female
Female
26%
Company-wide: 42%

Lexicon Pharmaceuticals executives by race

Management Team:
  • The most common ethnicity among Lexicon Pharmaceuticals executive officers is White.
  • 62% of the management team is White.
  • 15% of Lexicon Pharmaceuticals's management is Asian.
  • 10% of the management team is Black or African American.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 50% of employees are White.
  • 20% of employees are Asian.
  • 16% of employees are Hispanic or Latino.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Lexicon Pharmaceuticals jobs nearby

Lexicon Pharmaceuticals executives FAQs

Zippia gives an in-depth look into the details of Lexicon Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Lexicon Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Lexicon Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Lexicon Pharmaceuticals. The data presented on this page does not represent the view of Lexicon Pharmaceuticals and its employees or that of Zippia.

Lexicon Pharmaceuticals may also be known as or be related to LEXICON PHARMACEUTICALS INC., LEXICON PHARMACEUTICALS, INC., Lexicon Pharmaceuticals, Lexicon Pharmaceuticals Inc, Lexicon Pharmaceuticals, Inc and Lexicon Pharmaceuticals, Inc.